Skip to main content
Clinical Trials/ITMCTR2000003566
ITMCTR2000003566
Recruiting
Phase 1

The clinical trial of the interventional effect of Sini Decoction and Shengxian Quyu Decoction on myocardial inhibition in patients with sepsis

Guangdong Provincial Hospital of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Diagnostic criteria of Western medicine:
  • 1\. Patients with sepsis: (refer to the latest sepsis diagnostic criteria developed by SSC guidelines in 2016\)
  • (1\) Suspected or confirmed infection;
  • (2\) The sequential organ failure score (SOFA score) increased by 2 or more points above the baseline level, and it could be diagnosed as sepsis.
  • 2\. Myocardial suppression: at present, there is no unified diagnostic standard for sepsis myocardial injury at home and abroad. At present, the domestic and foreign literatures are consulted and the diagnosis process recognized by well\-known experts is followed. The presence of any of the following is suggestive of myocardial suppression:
  • (1\) Myocardial injury markers: c\-tni \> 0\.03ng/ml and c\-tnt \> 0\.017ng/ml.
  • (2\) Echocardiography: LVEF \< 50%, or FS \> 25%.
  • Diagnostic criteria of traditional Chinese Medicine
  • (refer to the TCM classification of sepsis according to the guidelines for the treatment of severe sepsis / septic shock in China issued in 2014\)
  • 1\. The body is tired and weak, with little Qi and lazy speech, pain in fixed parts, bleeding in some parts, and pain in chest and flank like needle pricking;

Exclusion Criteria

  • 1\. Patients with severe hepatic and renal insufficiency, patients with severe immune diseases or malignant tumors;
  • 2\. Patients with allergic constitution or allergic to traditional Chinese medicine decoction;
  • 3\. Patients unable to cooperate with the study and patients who died within 24 hours after admission to ICU;
  • 4\. Pregnant or lactating women;
  • 5\. Patients who participated in other studies.

Outcomes

Primary Outcomes

Not specified

Similar Trials